Fujifilm Diosynth Biotechnologies opens new UK lab

By Gareth Macdonald contact

- Last updated on GMT

New Fujifilm mAb lab at the Wilton Centre (source Wilton Centre website)
New Fujifilm mAb lab at the Wilton Centre (source Wilton Centre website)

Related tags: Biotechnology

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

The lab – at the Wilton Centre science park in Redcar, Cleveland – will provide support for customers developing monoclonal antibodies (mAbs) using Fujifilm’s Saturn cell culture process development platform.

COO Paul Found said by “by dedicating these facilities and bringing new technologies we will be effectively supporting our customer’s in the rapid delivery of monoclonal antibody therapies to patients all over the world​.”


The expansion is part of the $130m (€108m) bioreactor and processing capacity increase programme Fujifilm announced in April​.

The majority of the money was spent on the firm’s new facility in Texas, with the remainder being used to up capacity at its site in Billingham, UK.

The opening of the Teeside lab comes six months​ after GE Healthcare installed a single-use purification system with bioreactors at the Billingham facility.

In its first quarter fiscal report last month​ Fujifilm, the contract manufacturing organisation’s (CMO) parent company, said customer demand for flexible capacity prompted the investment.

In order to respond rapidly to demands for customer for increased production and other future expansions in demand, the company is also bolstering its capacity to produce bio-pharmaceuticals at its production centres​.”

Related news

Show more

Related products

show more

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Related suppliers

Follow us


View more